Vera Therapeutics' Drug to Reduce Proteinuria Gets FDA Approval
() -- Vera Therapeutics' (VERA) Trutakna has been approved to reduce proteinuria in adults with primary immunoglobulin A nephropathy, the US Food and Drug Administration said in a Tuesday statement. Trutakna is injected subcutaneously once weekly, the FDA said. IgA nephropathy is a serious kidney disease that occurs wh